玻璃体腔注射抗 VEGF 治疗对黄斑病 ( FFM ) 病例中脉络膜新生血管的长期疗效。
求助全文
Mesh : Angiogenesis Inhibitors / therapeutic use Antibodies, Monoclonal / therapeutic use Choroidal Neovascularization / drug therapy Humans Ranibizumab / therapeutic use Stargardt Disease
来 源: DOI:10.1055/a-1766-6623